Get tickets

Programme

Wednesday 7th December 2016

11:00 - 12:00

Registration & Refreshments

12:00 - 13:30

Networking buffet lunch in the Exhibition hall

13.30 - 13:45

Welcome & opening remarks

Gary Pitcairn, Chair, DDL Conference Committee

13:45 - 14:15

Conference Opening Plenary:

The European Asthma Research & Innovation Partnership – tackling Europe’s high asthma prevalence and death rates

Dr Samantha Walker, Director, Research & Policy and Deputy Chief Executive, Asthma UK

PRESENTATION SLIDES

Session 1: Inhalers – Were They Really Meant For Humans?

14:15 - 14:45

Inhaler device and errors

Professor Henry Chrystyn, Emeritus Professor, Inhalation Consultancy

14:45 - 16:15

Posters, Exhibition & Refreshments

Manned Poster Session

Posters 1 – 36

16:15 - 16:45

Human factor considerations in inhaler innovation

Mr Julian Dixon, Director of Human Factors, Team Consulting Ltd

PRESENTATION SLIDES

16:45 - 17:05

Clinically relevant in vitro tests for the assessment of innovator and generic nasal spray products

Mrs Mandana Azimi, Virginia Commonwealth University

PRESENTATION SLIDES

17:05 - 17:25

Innovations in nebulized delivery

Dr John N Pritchard, Respironics Respiratory Drug Delivery (UK) Ltd

PRESENTATION SLIDES

 

17:30 - 20:00

Exhibition Hall Drinks Reception

Lennox Suite

Drinks & Canapes for all attendees

Sponsored by vectura logo_a3

Thursday 8th December 2016

08:00 - 08:55

Registration & Refreshments

Exhibition hall and Poster viewing

08:55 - 09:00

Opening of Conference

09:00 - 09:45

Annual DDL Lecture

The challenge of delivering drugs to the lungs

Dr Stephen P. Steve Newman, Scientific Consultant

PRESENTATION SLIDES

09:45 - 10:15

Conference Plenary

Biologics in Asthma – are we turning the corner

Professor Roland Buhl, Mainz University Hospital

PRESENTATION SLIDES

10:15 - 11:30

Posters, Exhibition & Refreshments

Manned Poster Session

Posters 37 – 76

Session 2: Beyond Asthma and COPD

11:30 - 12:00

Development to Approval of NARCAN® Nasal Spray

Mr Fintan Keegan, Head of Technical Operations, Adapt Pharma

PRESENTATION SLIDES

12:00 - 12:15

New lung-tumour-penetrating nanocarrier designed for aerosolized chemotherapy

Dr Rémi Rosière, Université Libre de Bruxelles

PRESENTATION SLIDES

12:15 - 12:30

Oxytocin receptor expression but a lack of response to oxytocin in airway tissues

Mr Jibriil Ibrahim, Monash Institute of Pharmaceutical Sciences

PRESENTATION SLIDES

12:30 - 12:45

Anti-inflammatory activity of novel trans-stilbene sulfonamide analogues as potential novel therapeutic agents for lung disease

Mrs Rhamiya Mahendran, University of Hertfordshire

PRESENTATION SLIDES

12:45 - 14:00

Networking Lunch

Exhibition Hall & Poster viewing

 

Session 3: The Pat Burnell New Investigator Award

14:00 - 14:15

Characterisation of MRP1 in human distal lung epithelial cells in vitro

Mr Mohammed Ali Selo, Trinity College Dublin

PRESENTATION SLIDES

14:15 - 14:30

Carrier microstructure and performance of dry powder inhalation mixtures: A step towards universal performance prediction model

Mr Ahmed O. Shalash, European Egyptian Pharmaceutical Industries

PRESENTATION SLIDES

14:30 - 14:45

Development of inhalable drug formulations for idiopathic pulmonary fibrosis

Mr Ville Vartiainen, University of Helsinki

PRESENTATION SLIDES

14:45 - 15:00

Investigating the effect of the force control agent magnesium stearate in fluticasone propionate dry powder inhaled formulations with single particle aerosol mass spectrometry (SPAMS)

Mr Martin Jetzer, Novartis Pharma AG

PRESENTATION SLIDES

15:00 - 15:15

Influence of blender type on the performance of ternary dry powder inhaler formulations

Mr Mats Hertel, Kiel University

PRESENTATION SLIDES

15:15 - 16:00

Posters, Exhibition & Refreshments

Session 4: 60 Years of The pMDI

16:00 - 16:30

The future of propellants for pMDIs

Dr Tim Noakes, Medical Products Technical Associate, Mexichem, & Stuart Corr, Mexichem

PRESENTATION SLIDES

16:30 - 17:00

Next generation formulations for pMDIs

Professor Glyn Taylor, Director of Research, i2c Pharmaceutical Services

PRESENTATION SLIDES

17:00 - 17:20

Novel techniques for characterising inhalers

Dr Alan McKiernan, Prior PLM Medical

PRESENTATION SLIDES

17:20 - 17:40

Multi-physics theoretical approach to predict pMDI spray characteristics

Dr Barzin Gavtash, Loughborough University

PRESENTATION SLIDES

17:45 - 20:00

Entertainment Evening

Cromdale Hall

Including: Pat Burnell New Investigator Award, Best Academic Poster Award and Best Industrial Poster Award Prize Giving Ceremony

Join us for drinks, light food and great entertainment and network with your fellow conference attendees.

Sponsored By3M_lockup_CMYK_pos

 

Friday 9th December 2016

08:00 - 08:55

Registration & Refreshments

Exhibition hall and Poster viewing

Session 5: Innovations in Aerosol Delivery

09:00 - 09:30

Innovations in formulations to improve aerosol delivery

Professor Peter York, Chairman and Chief Scientist, CrystecPharma

PRESENTATION SLIDES

09:30 - 09:50

Aspergillus fumigatus in valved holding chambers: use of silver ion additive technology on fungal activity and aerosol delivery characteristics

Mr Mark Sanders, Clement Clarke International Ltd

PRESENTATION SLIDES

09:50 - 10:10

In-silico lung modeling platform for inhaled drug delivery

Dr Antonio Cabal, Merck & Co

10:10 - 11:20

Posters, Exhibition & Refreshments

11:20 - 11:50

m-health on asthma – friend or foe

Dr Stephen Fowler, The University of Manchester

PRESENTATION SLIDES

11:50 - 12:10

Polymer-protein-based dry powder for efficient pulmonary protein delivery

Mr Alejandro Nieto-Orellana, University of Nottingham

PRESENTATION SLIDES

12:10 - 12:40

Multiplexed optical molecular sensing and imaging in the lungs

Dr Kev Dhaliwal, University of Edinburgh

12:40 - 12:45

Concluding Remarks and Conference Close

Gary Pitcairn, Chair, DDL Conference Committee

 

12.45

DDL27 Conference Close